Kamada (KMDA) Enterprise Value (2015 - 2026)
Kamada's (KMDA) quarterly Enterprise Value came in at $353.3 million in Q2 2026, down 6.95% on a YoY basis from $379.7 million in Q2 2025, and down 13.4% quarter-over-quarter from $408.0 million in Q1 2026.
Analysis
Kamada (KMDA) Enterprise Value (2015 - 2026) Analysis & Trends
Kamada (KMDA) has reported Enterprise Value for 12 consecutive years, with $353.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Enterprise Value fell 6.95% year-over-year to $353.3 million; the trailing twelve-month figure through Jun 2026 stood at $353.3 million (down 6.95% YoY), and the FY2025 full-year result was $256.3 million, up 32.58% from the prior year.
- Enterprise Value eased to $353.3 million in Q2 2026 per KMDA's latest filing, from $408.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at $408.0 million in Q1 2026 and bottomed at $142.7 million in Q4 2022.
- Historically, Enterprise Value has averaged $251.4 million across 5 years, with a median of $232.6 million in 2024.
- The widest YoY moves for Enterprise Value: up 68.56% in 2023, down 19.62% in 2023.
- Over 5 years, Enterprise Value stood at $142.7 million in 2022, then jumped by 68.56% to $240.5 million in 2023, then decreased by 19.61% to $193.3 million in 2024, then surged by 32.58% to $256.3 million in 2025, then soared by 37.83% to $353.3 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered $353.3 million, $408.0 million, and $256.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Kamada | 473.57 Mn | 403.43 Mn | 22.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 353.28 Mn |
| Mar 31, 2026 | 407.95 Mn |
| Dec 31, 2025 | 256.33 Mn |
| Sep 30, 2025 | 327.09 Mn |
| Jun 30, 2025 | 379.68 Mn |
| Mar 31, 2025 | 303.86 Mn |
| Dec 31, 2024 | 193.34 Mn |
| Sep 30, 2024 | 236.66 Mn |
| Jun 30, 2024 | 228.55 Mn |
| Mar 31, 2024 | 274.27 Mn |
| Dec 31, 2023 | 240.49 Mn |
| Sep 30, 2023 | 186.80 Mn |
| Jun 30, 2023 | 214.71 Mn |
| Mar 31, 2023 | 181.13 Mn |
| Dec 31, 2022 | 142.67 Mn |
| Sep 30, 2022 | 170.80 Mn |
| Jun 30, 2022 | 202.02 Mn |
| Mar 31, 2022 | 225.33 Mn |
| Dec 31, 2021 | 149.49 Mn |
| Sep 30, 2021 | 137.30 Mn |